‘Deadpool & Wolverine’ poised for record-breaking R-Rated opening weekend

‘Deadpool & Wolverine’ is set to smash records with the highest R-rated debut and significant presales.


Pop Culture & Art July 26, 2024
Courtesy: Marvel Studios

This weekend marks the return of the “Merc with a Mouth” as “Deadpool & Wolverine” hits theaters, anticipated to achieve between $160 million and $180 million in domestic box office sales during its debut. 

This third stand-alone feature starring Ryan Reynolds is not only set to lead in R-rated openings for 2024 but also to break the record for the biggest debut ever for an R-rated film. 

The film, which is the 34th installment in the Marvel Cinematic Universe, is currently the top preseller of the year, surpassing previous records held by Disney and Pixar’s “Inside Out 2” and the first “Deadpool” film.

Mike Bowers, president and CEO of Harkins Theatres, predicts the film will set the benchmark for R-rated movies. “I think no question this is going to open as the largest R-rated movie of all time,” he stated. 

Ellis Jacob, president and CEO of Cineplex, concurs, noting that “Deadpool & Wolverine” is packed with Easter eggs, driving repeat viewings. The film’s secrecy and limited press screenings have fueled fan anticipation and heightened demand for premium screenings like IMAX and Dolby.

Marvel’s collaboration with theaters extends to exclusive merchandise, including collectible popcorn buckets and drink containers, which are expected to boost concession sales. 

This release is crucial for Marvel as Disney recalibrates its strategy following a series of underwhelming theatrical performances and a crowded streaming market. 

Shawn Robbins, founder of Box Office Theory, highlights the film’s appeal, saying it combines beloved personalities and high anticipation, offering a unique take on the MCU’s first R-rated entry.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ